Janet Hammond

Insider Reports History

Entity
Individual
Location
C/O Atea Pharmaceuticals, Inc., 125 Summer Street, Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Janet Hammond
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janet Hammond:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Chief Development Officer Restricted Stock Units 93.6K $483K $5.16 Jan 31, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Development Officer Common Stock 35.4K $136K $3.84 Feb 1, 2024 Direct
Atea Pharmaceuticals, Inc. Chief Development Officer Stock Option (Right to Buy) 225K Jan 31, 2024 Direct

Insider Reports Filed by Janet Hammond

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2024 4 -$53.9K 4 Feb 2, 2024 Chief Development Officer
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Development Officer
AVIR Atea Pharmaceuticals, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 Chief Development Officer